Cargando...
Thalidomide for Treating Metastatic Hepatocellular Carcinoma: A Pilot Study
BACKGROUND: Thalidomide has been reported to have antitumor activity for treating metastatic hepatocellular carcinoma (HCC). We evaluated the safety and efficacy of using thalidomide for treating selected patients with unresectable or metastatic HCC, and their disease was refractory to systemic chem...
Gardado en:
| Main Authors: | , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
The Korean Association of Internal Medicine
2006
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3891026/ https://ncbi.nlm.nih.gov/pubmed/17249503 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3904/kjim.2006.21.4.225 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|